1. Home
  2. VIAV vs IOVA Comparison

VIAV vs IOVA Comparison

Compare VIAV & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

N/A

Current Price

$35.33

Market Cap

7.3B

Sector

Technology

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$3.66

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIAV
IOVA
Founded
1923
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
1.6B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
VIAV
IOVA
Price
$35.33
$3.66
Analyst Decision
Strong Buy
Buy
Analyst Count
8
10
Target Price
$24.79
$9.11
AVG Volume (30 Days)
5.4M
18.8M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
14.84
EPS
N/A
N/A
Revenue
$1,084,300,000.00
N/A
Revenue This Year
$37.78
$51.55
Revenue Next Year
$10.64
$37.55
P/E Ratio
N/A
N/A
Revenue Growth
8.39
N/A
52 Week Low
$8.10
$1.64
52 Week High
$35.61
$5.63

Technical Indicators

Market Signals
Indicator
VIAV
IOVA
Relative Strength Index (RSI) 64.70 47.70
Support Level $26.56 $2.02
Resistance Level $35.61 $4.34
Average True Range (ATR) 2.22 0.42
MACD 0.14 -0.15
Stochastic Oscillator 93.15 10.45

Price Performance

Historical Comparison
VIAV
IOVA

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: